BD China

Working at BD China

 

 

 

About Us

BD officially established its representative office in China in 1994. Shanghai is the headquarters of BD China and in addition, there are 17 regional offices in different cities such as Beijing, Guangzhou and Chengdu. BD China with its 4,000 associates are committed to building a high-quality localised multinational company, with three manufacturing plants successively built in Suzhou. It has also established the BD Greater China R&D Center, as well as BD China Customer Service Center and Customer Experience Center serving more patients and healthcare workers in China, while helping advance the development of medical science.

BD Greater China R&D Center

Adhering to the guideline of In China, For China, BD China has developed a dual-center R&D strategy that situates the Innovation Design Center and Multifunctional Lab in Shanghai, and the Lab Engineering Center in Suzhou. Through detecting local customers' needs and discovering innovative opportunities, BD Greater China R&D Center develops customised products for Chinese customers and upgrades existing products. It also supports local registration and accelerates launch of new products, so as to support local customers and business teams.

Suzhou Plant I

  • Built in 1995 covering 40,000m2 area
  • 7,000m2 Class 100,000 clean rooms
  • Three Intima II automatic production lines, the first Pegasus automatic production line of BD
  • Awarded the Jiangsu Provincial Medical Instrument “Excellent and Integrity Company” title for 4 consecutive years

Suzhou Plant II

  • In 2005, covering 43,800m2 area
  • China 40 reagent went into local production
  • Hypak prefilled syringe production line
  • Honored as Advanced Company in Precursor Chemical Management by Suzhou Industrial Park

Suzhou Plant III

  • Construction completed in 2015 with 100 million USD investment in total
  • Covering 48,000m2 area with 4,500m2 world's top Class 100,000 clean rooms
  • Production of insulin injection pen needles and vacuum blood collection tubes
  • Quality control level surpasses other BD global plants
  • Selected as “National Medical Device QMS Model Company” by CFDA

Opportunities

As the second largest market among BD Worldwide, BD China has achieved outstanding growth in successive years with more than $1 billion in annualized revenue, which is inseparable from our continuous focus on and investment in local talent development and innovation efforts. Adhering to the guideline of “In China, for China”, BD China is committed to attracting, engaging, motivating and developing local talents with global mindset and innovative ideas. By promoting inclusion and diversity programs, BD China strives to create the best working environment that enable our diverse talent to be fully engaged, motivated and to fulfil their potentials. Join BD China to provide best class service to Chinese patients and healthcare workers, and together we can advance the world of health.

Find a position where you can make a difference and #joinbd.

Awards

We are extremely proud to announce that BD China was awarded Top Employer 2018-2020 three years in a row, and Aon 2017 Best Employers of China. In addition, BD Suzhou Plant was certified as Greater Suzhou Best Employer 2019 and 2020.

2020 Great Place To Work ® Certification

Aon Best Employers Award 2017

In the Universum China Most Attractive Employers Social Campaign 2018, BD China was ranked TOP 10 among health/medical students.

Best Companies for Female Executives 2019 - Silver Medal

In addition, in recognition of BD China’s unremitting efforts on inclusion and diversity, and female career development, we won the silver medal of the Best Companies for Female Executives.

View in Chinese

Go to top